iF488 Anti-Human CD127 (IL-7Rα) Antibody
英诺赛图(InnoCyto)的 iF488 Anti-Human CD127 (IL-7Rα) Antibody(克隆 127AM1) 为鼠源 IgG1 单克隆抗体,靶向 CD127(别名 IL-7 receptor α chain 等),iF488 标记(488 nm 蓝色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 iF488 Anti-Human CD127 (IL-7Rα) Antibody(克隆 127AM1) 为鼠源 IgG1 单克隆抗体,靶向 CD127(别名 IL-7 receptor α chain 等),iF488 标记(488 nm 蓝色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
104807 | 25 tests | ¥1,085
104808 | 100 tests | ¥2,983
104903 | 25 tests | ¥1,085
104904 | 100 tests | ¥2,983
Product Details
Regulatory Status|RUO
Protein Concentration|Supplied at a lot-specific concentration.
Storage&Handling|The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Recommended Usage|For flow cytometric staining, it is recommended to use 5 µL of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application. iF488 has an excitation max at 491 nm and an emission max at 516 nm.
See All Formats|Clone 127AM1
Background Information
CD127 is the α chain of the interleukin-7 receptor (IL-7Rα), a critical cytokine receptor involved in lymphocyte development, survival, and homeostasis. CD127 is expressed on multiple immune cell types, including naïve and memory CD4⁺ and CD8⁺ T cells, innate lymphoid cells (ILCs), and early B cell progenitors, while it is characteristically low or absent on regulatory T cells (Tregs). Because of this expression pattern, CD127 is widely used as a phenotypic marker to distinguish functional T cell subsets.
Structurally, CD127 is a type I transmembrane glycoprotein belonging to the class I cytokine receptor family. It consists of an extracellular domain containing conserved cytokine receptor motifs, a single transmembrane region, and a cytoplasmic tail that lacks intrinsic kinase activity. CD127 pairs with the common gamma chain (γc, CD132) to form the functional IL-7 receptor complex. Upon ligand binding, associated Janus kinases (JAK1 on CD127 and JAK3 on γc) are activated, leading to downstream signaling through STAT5 and other pathways that regulate cell survival and proliferation.
The primary ligand for CD127 is interleukin-7 (IL-7), a stromal cell–derived cytokine essential for T cell development in the thymus and for the maintenance of peripheral T cell pools. IL-7 signaling promotes lymphocyte survival by upregulating anti-apoptotic molecules such as BCL-2 and supports metabolic fitness and long-term immune competence. Tight regulation of CD127 expression ensures appropriate responsiveness to IL-7 and prevents excessive or dysregulated lymphocyte expansion.
CD127 is implicated in several diseases. Reduced CD127 expression on T cells is observed in chronic infections, cancer, and autoimmune diseases, often reflecting persistent immune activation or exhaustion. Genetic polymorphisms in the IL7R gene have been linked to susceptibility to autoimmune disorders, most notably multiple sclerosis. In contrast, aberrant IL-7/IL-7R signaling has been implicated in certain leukemias and lymphomas, where it may contribute to malignant cell survival and proliferation.
Therapeutically, CD127 and the IL-7 pathway are active areas of clinical interest. Recombinant IL-7 has been explored to enhance immune reconstitution in settings such as lymphopenia, HIV infection, and cancer immunotherapy, where boosting T cell numbers and function is desirable. Conversely, therapeutic strategies targeting CD127 signaling are being investigated for autoimmune and inflammatory diseases, aiming to dampen pathogenic T cell responses. In research and cell therapy, CD127 is also routinely used as a marker to identify memory T cells and to exclude regulatory T cells during immune profiling and cell product manufacturing.
Data Sheets
Human peripheral blood lymphocytes stained with iF488 Anti-Human CD127 clone 127AM1 (blue histogram) or an isotype control (gray histogram).
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). iF488 Anti-Human CD127 (IL-7Rα) Antibody(104903)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/if488-anti-human-cd127-il-7r-antibody-104903.html.
TeleVM. (2026, November 12). iF488 Anti-Human CD127 (IL-7Rα) Antibody(104903). 产品目录. https://www.suprotek.cn/products/item/if488-anti-human-cd127-il-7r-antibody-104903.html
@misc{biocsp_item_if488_anti_human_cd127_il_7r_antibody_104903,
title = {iF488 Anti-Human CD127 (IL-7Rα) Antibody(104903)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/if488-anti-human-cd127-il-7r-antibody-104903.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源